MDW Capital advises Longacre and Inuvi Group, the Firm’s 85th completion
London, 25th March 2025
MDW Capital is pleased to announce the successful completion of its latest transaction. The Firm has advised Inuvi Group Ltd (“Inuvi”), a market-leading provider of diversified health services delivering health assessments, laboratory testing, and community diagnostics throughout the UK and Ireland, on securing debt facilities to both refinance existing debt and support a bolt on acquisition.
Headquartered in Wokingham and operating a state-of-the-art laboratory facility in Gloucester, Inuvi delivers integrated diagnostic solutions, from sample collection and health assessments through to results testing, analysis and interpretation. Since Longacre’s original investment in 2019, the partnership with Jonathan Benton, Inuvi’s Founder and CEO, has seen the Group achieve significant organic growth, further accelerated by four strategic acquisitions, the most recent being Physiological Measurements Limited funded as part of this transaction.
Inuvi and Longacre, the long-term investment firm established by Stani Schmidt-Chiari and Elliott Nicholson with a focus on sustainable development of B2B enterprises, engaged MDW Capital to provide strategic capital advice and arrange a comprehensive financing package from a new lender to position the business for its next chapter of growth.
Stani Schmidt-Chiari of Longacre commented: “This refinancing, coupled with Inuvi’s excellent growth and recent strategic acquisitions, marks a transformational milestone that will enable the Group to expand on its specialist service offering. MDW Capital’s business-focused approach, with a strong emphasis on understanding companies’ commercial strengths, key attributes and wholistic funding needs is matched by the quality of their skill in articulating the credit story to funding partners and negotiating the best possible terms. With their hands-on style and deep understanding of the borrower’s and our own needs, MDW worked as an integral part of our deal team. More importantly, they have delivered a superb outcome for us, creating a capital structure that blends high flexibility and future growth funding.”
Jacco Brouwer, Partner at MDW Capital added: “Inuvi’s journey so far has been hugely impressive. We have greatly enjoyed partnering with management and the shareholders to secure this milestone new financing that realigns the capital structure with the growth achieved to date and future strategic objectives. Yet again, our investor and borrower expertise, combined with business and sector insights, have combined to provide a significantly differentiated service and outcome for our clients. We congratulate the Longacre and Inuvi teams on the refinancing, which marks MDW’s 85th in just over six years, and look forward to tracking the continued success of the business.”
Contact details:
| Andrew Aylwin
M: +44 777 177 3411 |
David Culpan
M: +44 7734 388 762 |
Jacco Brouwer
M: +44 7561 805 501 |
About MDW Capital
MDW Capital provides specialist capital advisory services to companies and their shareholders. Primarily focused on the European market, and with a greater global reach when needed, MDW Capital’s mission is to solve clients’ capital challenges, using the team’s deep experience and relationships gained from raising in excess of €15 billion of capital, in more than 235 transactions across Europe, the US and the Far East, from over 75 lenders and more than 40 institutional investors.
The partners’ background as investors, lenders and borrowers brings a new perspective to capital advisory. Their background, track record and approach of partnering with companies over a number of years sets MDW Capital apart, whether advising or as a board member, managing or overseeing the long-term relationships with capital providers, or supporting management teams and investors throughout the life of an investment.
Most importantly, MDW understands that capital is about more than just the money.
About Inuvi
Founded in 2015, Inuvi is a market leading diversified health services company which offers end-to-end diagnostic services from initial sample collection and assessments through to results analysis. It operates across three core divisions including Health Assessments & Phlebotomy, Laboratory Testing, and Community Diagnostics, serving a diverse customer base comprising blue chip insurance providers, the NHS, and corporates (including consumer and occupational health companies). In 2019, a majority stake was acquired by Longacre Group Limited.
About Longacre Group
Longacre Group, founded in 2014 by Stani Schmidt-Chiari and Elliott Nicholson, focuses on B2B companies in four core sectors: technical manufacturing, business services, speciality chemicals, and healthcare products and services. Longacre Group provides evergreen capital and a team of world-class operating partners, underpinning the firm’s flexible approach to business and quick, transparent decision-making.